药品注册申请号:076380
申请类型:ANDA (仿制药申请)
申请人:BARR
申请人全名:BARR LABORATORIES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 JUNEL 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG No No AB 2003/05/30 2003/05/30 Prescription
批准历史,通知信,药品说明书,综述等审批信息
批准日期申请类型申请提交号审查批准结论申请内容分类审评分类(优先审评;罕用药状态)通知信、综述、标签、说明书备注
2004/10/20 SUPPL 4 Approval Labeling
2003/05/30 ORIG 1 Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 剂型/给药途径:TABLET;ORAL-21 规格:0.02MG;1MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017876 001 NDA LOESTRIN 21 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription Yes No AB Approved Prior to Jan 1, 1982 APIL
076380 001 ANDA JUNEL 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2003/05/30 BARR
075647 002 ANDA MICROGESTIN 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2003/07/30 MAYNE PHARMA
077077 002 ANDA GILDESS 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2012/07/24 VINTAGE PHARMS LLC
202771 001 ANDA NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2013/11/06 MYLAN LABS LTD
202995 001 ANDA LARIN 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2013/12/04 NOVAST LABS
206969 001 ANDA NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2016/01/20 GLENMARK PHARMS LTD
207506 001 ANDA AUROVELA 1/20 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL-21 0.02MG;1MG Prescription No No AB 2017/06/16 AUROBINDO PHARMA LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2019 DrugFuture->U.S. FDA Drugs Database